A complete hydatidiform mole or very rarely a partial mole that invades the myometrium.
Comprehensive, easy-to-understand information about this condition
How we create this content →Report Generation Failed
We couldn't automatically generate the report. This may be due to temporary service issues.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
Organizations with orphan designations or approved therapies for this disease
AIM ImmunoTech Inc.
Other
Astellas Pharma Global Development, Inc.
Other
Basilea Pharmaceutica Ltd, Allschwil
Other
CancerVax Corporation
Other
F2G Limited
Other
IDEC Pharmaceuticals Corporation
Other
Merck Sharp & Dohme LLC
Other
SCYNEXIS, Inc.
Other
Statens Seruminstitut
Other
The Liposome Company, Inc.
Other